Information for the Media

About MHRP

• MHRP Fact Sheets
• MHRP Brochure

Press Releases

September 10, 2012
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses

April 5, 2012
Follow-up Studies to the RV144 HIV Vaccine Trial Provide Possible Explanation for How the Vaccine May Have Protected Against HIV

RV144 Follow-up FAQs

Jan. 4, 2012
Promising Results of Novel Combination HIV Vaccine: Preclinical Study of HIV Vaccine Candidates Provides Strong Rationale 
for Clinical Trials

Sept. 13, 2011
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect On Disease Progression In Infected Volunteers

Sept. 28, 2010
Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins

Dec. 15, 2009
New Insight Into Selective Binding Properties of Infectious HIV

Oct. 20, 2009
Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research

Sept. 24, 2009
HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV

RV144 FAQs

Sept. 1, 2009
Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids

MHRP in the News

• Reuters (7/15/12): Scientists see AIDS vaccine within reach after decades
• Bloomberg (6/27/12): Shark Oil for HIV Shot Takes Cue From Hemingway's Old Man
• VOA (4/5/12): Clues Found for AIDS Vaccine Trial Success
• WTOP (1/13/2012): HIV Study Offers Hope Toward Vaccine Development
• Wall Street Journal (1/5/2012): Search for AIDS Vaccine Advances
• CNN (1/5/2012): Experimental Vaccine Helps Protect Monkeys Against AIDS-like Infection
• Reuters (1/4/2012): Study in Monkeys Raises Hope for HIV Vaccines
• AIDS Vaccine 2011 coverage
• Washington Post (7/4/2011): A Glimmer of a Path to an AIDS Vaccine
• Wall Street Journal (6/18/2011): Thirty Years of Fighting AIDS: A Progress Report
• IAVI Report (3/2010): Building on RV144
• MedPage Today (2/18/2010): CROI: Thai Trial Invigorates HIV Vaccine Hunt
• Time Magazine: The 50 Best Inventions of 2009
• Discover (1/25/2010): Top 100 Stories of 2009 #13: Hope for HIV Vaccine
• BBC (10/20/2009): HIV vaccine trial was significant
• New York Times (9/24/2009): For First Time, AIDS Vaccine Shows Some Success 
• CNN (9/24/2009): Combo vaccine reduces risk of HIV infection, researchers say

Photo Gallery

(Photo Credit: MHRP)

	Download (JPG) Morgane Rolland, Ph.D. Bioinformatics Section Chief, Department of Molecular Virology and Pathogenesis, MHRP
	Download (JPG) Alignment of Env-V2 amino acid sequences isolated from vaccine and placebo recipients in the RV144 trial.
	Download (JPG) DNA sequencer used to sequence nearly 1,000 HIV-1 genomes from breakthrough infections in RV144.
	Download (JPG) Nelson Michael, M.D., Ph.D. COL, MC, U.S. Army Director, MHRP
	Download (JPG) Jerome Kim, M.D. COL, MC, U.S. Army Deputy Director, MHRP
	Download (JPG) RV144 tested the “prime-boost” combination of two vaccines: ALVAC® HIV vaccine (the prime) and AIDSVAX® B/E vaccine (the boost).
	Download (JPG) Laboratories at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand.
*This joint U.S.-Royal Thai Army research institute helped execute RV144 in Thailand on behalf of the trial Sponsor, the U.S. Army Surgeon General.

• Lisa Reilly

  Communications Director

  lreilly@hivresearch.org

  301.500.3633

Global Efforts

Our dedicated researchers and support staff are working to stop the spread of HIV/AIDS around the world.

Nigeria, Kenya, Tanzania,
Uganda, Thailand, U.S., Mozambique

Join MHRP on Facebook

Follow MHRPInfo on Twitter

Subscribe to MHRPvideos

View MHRP photo galleries on Flickr